IP Library Granted Patent US 9,382,291
Granted Patent B2
US 9,382,291 · App. 14/166,007 · Granted Jul 5, 2016

Gamma amino acid building blocks

Inventors: Samuel Helmer Gellman (Madison, WI); Li Guo (Blue Bell, PA); Michael Giuliano (Derby, CT)
Assignee: Wisconsin Alumni Research Foundation
C07K7/06C07C201/12C07C205/44C07C205/55C07C233/48C07C237/24C07C269/00C07C271/24C07C271/66C07D211/56C07D211/60C07K5/0205C07K5/06078C07K5/1016C07C2101/08C07C2101/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,382,291
App. No.
14/166,007
Granted
Jul 5, 2016
Kind
B2
Abstract

The invention provides compounds and methods, for example, to carry out organocatalytic Michael additions of aldehydes to cyclically constrained nitroethylene compounds catalyzed by a proline derivative to provide cyclically constrained α-substituted-γ-nitro-aldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96 to >99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to cyclically constrained protected γ-amino acid residues, which are essential for systematic conformational studies of γ-peptide foldamers. New methods are also provided to prepare other γ-amino acids and peptides. These new building blocks can be used to prepare foldamers, such as α/γ-peptide foldamers, that adopt specific helical conformations in solution and in the solid state.

Claims (114)

1. A compound of Formula I:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle;

R 2 is H, OH, an amino acid or peptide, or OR x wherein R x is alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, or an oxygen protecting group;

Y is nitro, amino, a nitrogen bonded to an amino acid, —NHR y , or —N(R y ) 2 , wherein each R y is independently alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, or a nitrogen protecting group;

Z is O, S, or H, and the dashed line to Z is an optionally present bond that is absent when Z is H;

A 3 is carbon;

A 4 is carbon or nitrogen;

A 5 is carbon, or nitrogen provided A 6 is not a direct bond;

A 6 is carbon or a direct bond;

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or when nitrogen, one nitrogen protecting group; and

wherein each alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of any R 1 , R 2 , R x , or R y is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

or a salt or solvate thereof.

2. The compound of claim 1 wherein the compound is a compound of Formula IA:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

R 2 is H, OH, an amino acid or peptide, or OR x wherein R x is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R x is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

A 3 is carbon;

A 4 is carbon or nitrogen;

A 5 is carbon, or nitrogen provided A 6 is not a direct bond;

A 6 is carbon or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or when nitrogen, one nitrogen protecting group;

or a salt or solvate thereof.

3. The compound of claim 1 wherein the compound is a compound of Formula II:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

Y is nitro, amino, protected amino, or a nitrogen bonded to an amino acid;

R 3 is an amino acid side chain;

P is hydrogen, a carboxylic acid protecting group, or —OP is an amino acid residue or peptide;

A 3 is carbon;

A 4 is carbon or nitrogen;

A 5 is carbon or nitrogen;

A 6 is carbon or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group;

or a salt or solvate thereof.

4. The compound of claim 3 wherein R 1 is alkyl, A 3 -A 6 are each carbon, R 3 is H or alkyl, P is H, methyl or acetyl, and Y is nitro or protected amino.

5. A method for preparing a compound of claim 1 wherein R 2 is H comprising:

contacting a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring and that optionally includes one or two nitrogen atoms in the ring, wherein the carbon atoms in the ring are optionally substituted and the optional nitrogen atom or atoms in the ring are optionally substituted by a nitrogen protecting group; and

an aldehyde that has at least one α-hydrogen;

in the presence of an organic solvent, and a proline derivative, for a period of time sufficient to provide the compound of claim 1 .

6. The method of claim 5 wherein the aldehyde has an α-methylene group or an α-methine group.

7. The method of claim 5 wherein the contacting is carried out in the presence of a carboxylic acid, the proline derivative is a chiral pyrrolidine catalyst, and the compound of claim 1 is prepared in at least about 80% enantiomeric purity.

8. The method of claim 5 further comprising reducing an aldehyde moiety of the compound of claim 1 to an alcohol, oxidizing the resulting alcohol to a carboxylic acid, reducing the nitro moiety of the compound of claim 1 to an amine, or a combination thereof.

9. A method for preparing a compound of Formula III:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

A 3 is carbon;

A 4 is carbon or nitrogen;

A 5 is carbon, or nitrogen provided that A 6 is not a direct bond;

A 6 is carbon, or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups, or one nitrogen protecting group; or a salt or solvate thereof;

comprising contacting:

a compound of Formula IV:

wherein R 1 is as defined for Formula III; and

a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring and that optionally includes one or two nitrogen atoms in the ring, wherein the carbon atoms in the ring are optionally substituted and the optional nitrogen atom or atoms in the ring are optionally substituted by a nitrogen protecting group;

in the presence of an organic solvent and a proline derivative, for a period of time sufficient to provide the compound of Formula III.

10. A compound of Formula I:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle;

R 2 is H, OH, an amino acid or peptide, or OR x wherein R x is alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, or an oxygen protecting group;

Y is nitro, amino, a nitrogen bonded to an amino acid, —NHR y , or —N(R y ) 2 , wherein each R y is independently alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, or a nitrogen protecting group;

Z is O, S, or H, and the dashed line to Z is an optionally present bond that is absent when Z is H;

A 3 is carbon;

A 4 is carbon;

A 5 is carbon;

A 6 is carbon or a direct bond;

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups; and

wherein each alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of any R 1 , R 2 , R x , or R y is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

or a salt or solvate thereof.

11. The compound of claim 10 wherein A 6 is carbon.

12. The compound of claim 10 wherein the compound is a compound of Formula IA:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

R 2 is H, OH, an amino acid or peptide, or OR x wherein R x is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R x is optionally substituted with one to five alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, alkylaminoalkyl, dialkylaminoalkyl, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

A 3 is carbon;

A 4 is carbon;

A 5 is carbon;

A 6 is carbon or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, optionally protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, optionally protected amino, optionally protected aminoalkyl, optionally protected alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, optionally protected carboxy, optionally protected carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

or a salt or solvate thereof.

13. The compound of claim 12 wherein A 6 is carbon.

14. The compound of claim 10 wherein the compound is a compound of Formula II:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

Y is nitro, amino, protected amino, or a nitrogen bonded to an amino acid;

R 3 is an amino acid side chain;

P is hydrogen, a carboxylic acid protecting group, or —OP is an amino acid residue or peptide;

A 3 is carbon;

A 4 is carbon;

A 5 is carbon;

A 6 is carbon or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, fluoro, hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

or a salt or solvate thereof.

15. The compound of claim 14 wherein R 1 is alkyl, A 3 -A 6 are each carbon, R 3 is H or alkyl, P is H, methyl or acetyl, and Y is nitro or protected amino.

16. A method for preparing a compound of claim 10 wherein R 2 is H comprising:

contacting a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring, wherein the carbon atoms in the ring are optionally substituted; and

an aldehyde that has at least one α-hydrogen;

in the presence of an organic solvent, and a proline derivative, for a period of time sufficient to provide the compound of claim 10 .

17. The method of claim 16 wherein the aldehyde has an α-methylene group or an α-methine group.

18. The method of claim 16 wherein the contacting is carried out in the presence of a carboxylic acid, the proline derivative is a chiral pyrrolidine catalyst, and the compound of claim 10 is prepared in at least about 80% enantiomeric purity.

19. The method of claim 16 further comprising reducing an aldehyde moiety of the compound of claim 10 to an alcohol, oxidizing the resulting alcohol to a carboxylic acid, reducing the nitro moiety of the compound of claim 10 to an amine, or a combination thereof.

20. A method for preparing a compound of Formula III:

wherein

R 1 is alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle; wherein the alkyl, cycloalkyl, aryl, heteroaryl, or heterocycle of R 1 is optionally substituted with one to five alkyl, alkoxy, fluoro, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups;

A 3 is carbon;

A 4 is carbon;

A 5 is carbon;

A 6 is carbon, or a direct bond; and

each of A 3 -A 6 are optionally substituted with one or two alkyl, alkoxy, halo, protected hydroxy, aryl, (aryl)alkyl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, protected amino, alkylamino, dialkylamino, acylamino, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, arylsulfonyl, cyano, or azide groups; or a salt or solvate thereof;

comprising contacting:

a compound of Formula IV:

wherein R 1 is as defined for Formula III; and

a cyclic compound of 5 or 6 ring atoms that includes a nitroethylene moiety within the ring, wherein the carbon atoms in the ring are optionally substituted;

in the presence of an organic solvent and a proline derivative, for a period of time sufficient to provide the compound of Formula III.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 15, 2014
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 033320/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2014
From: GELLMAN, SAMUEL; GIULIANO, MICHAEL; GUO, LI
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 032193/0909 →
Continuity (3)
Division 12904942 · Oct 14, 2010
Provisional Application 61251630 · Oct 14, 2009
Related Publication 20150148523A1 · May 28, 2015